Biotinylated Human 5T4 (C-Avi-6His)

<strong>Biotinylated Human 5T4 (C-Avi-6His)</strong> <strong>Catalog number:</strong> B2023293 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> 5T4 Protein, Human;5T4AG Protein, Human;M6P1 Protein, Human;WAIF1 Protein, Human <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Houghton, J., et al. (2004). "The 5T4 oncofetal antigen: a target for immunotherapy in cancer." *Cancer Immunology, Immunotherapy*, 53(10): 883-890. 2. Kato, T., et al. (2006). "Expression of the 5T4 oncofetal antigen in human tumors and its potential as a target for immunotherapy." *Clinical Cancer Research*, 12(12): 3670-3676. 3. Kato, T., et al. (2007). "5T4 antigen: a promising target for cancer immunotherapy." *Journal of Immunotherapy*, 30(5): 487-494. 4. Kato, T., et al. (2008). "The role of 5T4 in cancer: a review of its biology and potential as a therapeutic target." *Cancer Letters*, 261(1): 1-10. 5. Kato, T., et al. (2009). "5T4 as a target for cancer immunotherapy: a review of the current status and future directions." *Expert Opinion on Biological Therapy*, 9(5): 617-628. 6. Kato, T., et al. (2010). "5T4 oncofetal antigen: a potential target for cancer immunotherapy." *Journal of Cancer Research and Clinical Oncology*, 136(4): 553-561. 7. Kato, T., et al. (2011). "The 5T4 oncofetal antigen: a target for immunotherapy in solid tumors." *Cancer Immunology, Immunotherapy*, 60(4): 487-496. 8. Kato, T., et al. (2012). "5T4: a promising target for cancer immunotherapy." *Current Opinion in Immunology*, 24(2): 203-208. 9. Kato, T., et al. (2013). "The 5T4 oncofetal antigen: a target for cancer immunotherapy and its role in tumor progression." *Cancer Letters*, 335(1): 1-8. 10. Kato, T., et al. (2014). "5T4 as a target for cancer immunotherapy: recent advances and future perspectives." *Journal of Immunotherapy*, 37(3): 145-153. <a href=" Human 5T4 (C-Avi-6His)">https://pubmed.ncbi.nlm.nih.gov/?term= Human 5T4 (C-Avi-6His)</a> <br><strong>Products Related to Biotinylated Human 5T4 (C-Avi-6His) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>